Petmed Express IncPETS
Price$1.37

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $168.9M-25.6% YoYTTM through 30 Jun 2026
Net Income -$29.3MTTM through 30 Jun 2026
Free Cash Flow -$27.8MTTM through 30 Jun 2026

Margins

Current
Gross Margin28.1%
EBITDA Margin-12.7%
Operating Margin-15.9%
Net Margin-17.3%

Returns

-100.4%ROE
-15.4%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio0.80x
Net Debt-$21.4Mnet cash position
Cash & Equivalents$13.1M

Quality Metrics

Altman Z-Score1.38
Piotroski F-Score1 / 9
FCF Margin-16.4%
Rule of 40-9.7
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'23'24'25'26
FY2026: $179M
Diluted EPS-$1.37TTM
'20'21'22'23'24'25'26
FY2026: $-2.74

Dividend

$0.90Per share, FY20230.00%Yield-2.9%5-yr growth

Capital Allocation

Capex Intensity2.3%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.